Biotech News
LeMaitre to Participate at Upcoming Investor Conferences in September
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.
Wells Fargo 21 st Annual Healthcare Conference Tuesday, September 8, 2026, in Boston Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET
Morgan Stanley 24 th Annual Global Healthcare Conference Wednesday, September 16, 2026, in New York City Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET
19 th Annual Barrington Research Virtual Fall Investment Conference Tuesday, September 22, 2026 Dorian LeBlanc, CFO, time to be announced
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.
LeMaitre is a registered trademark of LeMaitre Vascular, Inc.
Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 [email protected]
